Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Archives of Medical Science : AMS|July 25, 2024
Genomic profiling of thymoma using a targeted high-throughput approachJelena Peric, Natalija Samaradzic, Vesna Skodric Trifunovic, et al.
Archives of Medical Science : AMS|May 11, 2026
Expression pattern of circulating long non-coding RNA GAS5 as a novel biomarker in non-small cell lung cancer patientsNatasa Vesovic, Natasa Tosic, Teodora Karan Djurasevic, et al.
Inflammatory Bowel Diseases|August 27, 2024
Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal InflammationSanja Dragasevic, Biljana Stankovic, Nikola Kotur, et al.
International Journal of Laboratory Hematology|November 6, 2023
Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemiaNatasa Kacanski, Jovanka Kolarovic, Tatjana Kostic, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 20, 2020
Expression Pattern and Prognostic Significance of EVI1 Gene in Adult Acute Myeloid Leukemia Patients with Normal KaryotypeIrena Marjanovic, Teodora Karan-Djurasevic, Tatjana Kostic, et al.
Radiology and Oncology|April 20, 2023
The influence of BCL2, BAX, and ABCB1 gene expression on prognosis of adult de novo acute myeloid leukemia with normal karyotype patientsZlatko Pravdic, Nada Suvajdzic Vukovic, Vladimir Gasic, et al.
Annals of Hematology|June 21, 2007
Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemiaNatasa Colovic, Natasa Tosic, Sanja Aveic, et al.
International Journal of Laboratory Hematology|December 13, 2019
The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patientsMirjana Mitrovic, Tatjana Kostic, Marijana Virijevic, et al.
International Journal of Molecular Sciences|May 27, 2023
Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?Marina Jelovac, Nikola Kotur, Bojan Ristivojevic, et al.
Pageof 14